WARPTECHNEWS · LAB

Home AI Business Tech Archive

Storia: Pill offers hope in treating deadly pancreatic cancer — Warptech Lab News

Storia in 17 fonti

Pill offers hope in treating deadly pancreatic cancer

Pill users lived an average of 13.2 months versus 6.7 months for those undergoing chemotherapy

Raccontata da

biopharmadive.com

medpagetoday.com

independent.co.uk

theguardian.com

inews.co.uk+5 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

theweek.comStai leggendo3 mesi fa

Pill offers hope in treating deadly pancreatic cancer

Pill users lived an average of 13.2 months versus 6.7 months for those undergoing chemotherapy

independent.co.uk

Timeline cronologica

sabato 30 maggio 2026·pbs.org
Pancreatic cancer is deadly and difficult to treat. A new pill could change that
The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.
domenica 31 maggio 2026·biopharmadive.com
‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer
Highly anticipated data presented at ASCO confirmed what’s been heralded as a medical breakthrough against a historically tough-to-treat tumor.

3 mesi fa

Experimental pill promises new hope for deadly pancreatic cancer

New research shows a novel pill is helping people with advanced pancreatic cancer live longer

Leggi questa versione → originale

cnn.com3 mesi fa

Experimental pill promises new hope for deadly pancreatic cancer | CNN

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer.

Leggi questa versione → originale

sciencealert.com3 mesi fa

Breakthrough Pill Nearly Doubles Survival Time For One of The Deadliest Cancers

WASHINGTON (AP) – A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer.

Leggi questa versione → originale

dailysabah.com3 mesi fa

Experimental pill offers breakthrough hope in pancreatic cancer fight

Daraxonrasib, a daily oral KRAS inhibitor by Revolution Medicines, nearly doubled median survival in metastatic pancreatic cancer (13.2 vs 6.7 months) in a 500-patient Phase 3 trial, with the FDA fast-tracking review. The drug breaks a decades-long stalemate on KRAS — mutated in 90%+ of pancreatic cases — signaling that the "undruggable" oncology target class is now open, with downstream implications for RAS-driven cancers beyond pancreatic.

Leggi questa versione → originale

newscientist.com3 mesi fa

'Transformative' pancreatic cancer drug doubles survival time

Daraxonrasib doubled survival to 13.2 months (vs 6.7) in 500 treatment-resistant pancreatic cancer patients, with 90% lower side-effect dropout rates. First KRAS breakthrough in two decades; signals precision medicine momentum for oncology data stack and biotech investment decisions.

Leggi questa versione → originale

domenica 31 maggio 2026·

medpagetoday.com

'Grand Slam' in Pancreatic Cancer: Novel Pill Doubles Survival

RASolute 302 findings herald a new standard of care in previously treated patients

domenica 31 maggio 2026·

independent.co.uk

Daily pill almost doubles survival time for pancreatic cancer patients in new trial

Daraxonrasib has been hailed as ‘landscape-changing’ for people with the disease

domenica 31 maggio 2026·

theguardian.com

Daily pill can double survival time for world’s deadliest cancer, trial shows

Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer

domenica 31 maggio 2026·

dailymail.com

New drug gives extra months of life to pancreatic cancer patients

Doctors today hailed a breakthrough in the fight against pancreatic cancer after a new drug was shown to give patients precious extra months of life.

domenica 31 maggio 2026·

independent.co.uk

Experimental pill promises new hope for deadly pancreatic cancer

New research shows a novel pill is helping people with advanced pancreatic cancer live longer

domenica 31 maggio 2026·

mirror.co.uk

Cancer breakthrough as new 'game-changing' pill could double survival time

Prostate cancer patients normally have a devastatingly short life expectancy - but the new daily pill being offered in clinical trials could change that

domenica 31 maggio 2026·

independent.co.uk

Pancreatic cancer breakthrough as pill almost doubles survival time for patients

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

domenica 31 maggio 2026·

cbsnews.com

New drug nearly doubles survival rates in some pancreatic cancer patients, study says

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

domenica 31 maggio 2026·

fortune.com

Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually started crying' | Fortune

The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for…

domenica 31 maggio 2026·

cnn.com

Experimental pill promises new hope for deadly pancreatic cancer | CNN

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types…

domenica 31 maggio 2026·

dailysabah.com

Experimental pill offers breakthrough hope in pancreatic cancer fight

An experimental drug for advanced pancreatic cancer significantly extended survival in a major clinical trial, offering fresh hope for improved treatment...

domenica 31 maggio 2026·

inews.co.uk

Why this new pill for a deadly cancer has doctors excited

The results of a clinical trial of a new drug could signal a breakthrough in treating pancreatic cancer

domenica 31 maggio 2026·

pbs.org

Experimental drug shows promise against deadly pancreatic cancer

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types…

lunedì 1 giugno 2026·

sciencealert.com

Breakthrough Pill Nearly Doubles Survival Time For One of The Deadliest Cancers

WASHINGTON (AP) – A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of…

lunedì 1 giugno 2026·

benzinga.com

Revolution Medicines' Pancreatic Cancer Pill Doubles Survival, Cuts Death Risk 60% in Trial As Stock Sits

Few cancers have proven as difficult to treat as pancreatic cancer, making any sign of a survival breakthrough a major event for both patients and investors.

lunedì 1 giugno 2026·

newsbytesapp.com

This drug can double survival time for pancreatic cancer patients

A groundbreaking daily pill has been shown to double survival time for patients battling the world's deadliest cancer, marking a major advancement in medical research.

lunedì 1 giugno 2026·

abcnews.com

Experimental pancreatic cancer drug offers new hope in major trial

Phase 3 results showed the treatment nearly doubled survival for patients with previously treated metastatic pancreatic cancer.

lunedì 1 giugno 2026·

theweek.com

Pill offers hope in treating deadly pancreatic cancer

Pill users lived an average of 13.2 months versus 6.7 months for those undergoing chemotherapy

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com